ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,28
1,13%
Dow Jones
41 488,19
1,65%
DAX
22 986,82
2,01%
Brent Oil
70,285
0,00%
Bitcoin
82 694,86
-1,96%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Codexis Inc (CDXS)

  7. Codexis Inc (CDXS) Actualités

CDXS

Codexis (CDXS)

Codexis Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CDXS
DateHeureSourceTitreSymboleSociété
14/03/202521h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
07/03/202522h05GlobeNewswire Inc.Codexis Announces New Employment Inducement GrantsNASDAQ:CDXSCodexis Inc
27/02/202522h20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CDXSCodexis Inc
27/02/202522h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
27/02/202522h05GlobeNewswire Inc.Codexis Reports Fourth Quarter and Fiscal Year 2024 Financial ResultsNASDAQ:CDXSCodexis Inc
18/02/202522h05GlobeNewswire Inc.Codexis to Participate in TD Cowen 45th Annual Health Care ConferenceNASDAQ:CDXSCodexis Inc
13/02/202522h05GlobeNewswire Inc.Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27thNASDAQ:CDXSCodexis Inc
06/02/202522h05GlobeNewswire Inc.Codexis Appoints Arthur Levin, PhD, to Strategic Advisory BoardNASDAQ:CDXSCodexis Inc
16/01/202522h05GlobeNewswire Inc.Codexis Appoints Christos Richards to Board of DirectorsNASDAQ:CDXSCodexis Inc
19/11/202422h05GlobeNewswire Inc.Codexis to Participate in Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:CDXSCodexis Inc
14/11/202422h53Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDXSCodexis Inc
14/11/202422h05GlobeNewswire Inc.Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi TherapeuticsNASDAQ:CDXSCodexis Inc
12/11/202422h25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
12/11/202422h05GlobeNewswire Inc.Codexis Announces Appointment of Raymond De Vré, PhD, to Board of DirectorsNASDAQ:CDXSCodexis Inc
11/11/202422h05GlobeNewswire Inc.Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi TherapeuticsNASDAQ:CDXSCodexis Inc
04/11/202422h05GlobeNewswire Inc.Codexis to Participate in Upcoming Healthcare ConferencesNASDAQ:CDXSCodexis Inc
31/10/202421h18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDXSCodexis Inc
31/10/202421h05GlobeNewswire Inc.Codexis Reports Third Quarter 2024 Financial ResultsNASDAQ:CDXSCodexis Inc
24/10/202422h05GlobeNewswire Inc.Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual MeetingNASDAQ:CDXSCodexis Inc
22/10/202422h05GlobeNewswire Inc.Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of DirectorsNASDAQ:CDXSCodexis Inc
10/10/202422h05GlobeNewswire Inc.Codexis to Report Third Quarter 2024 Financial Results on October 31NASDAQ:CDXSCodexis Inc
02/10/202422h05GlobeNewswire Inc.Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of CompanyNASDAQ:CDXSCodexis Inc
01/10/202413h05GlobeNewswire Inc.Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciencesNASDAQ:CDXSCodexis Inc
26/09/202415h27Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CDXSCodexis Inc
18/09/202422h50Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDXSCodexis Inc
20/08/202422h05GlobeNewswire Inc.Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual MeetingNASDAQ:CDXSCodexis Inc
15/08/202422h05GlobeNewswire Inc.Codexis Publishes FY2023 Sustainability DisclosuresNASDAQ:CDXSCodexis Inc
09/08/202422h01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CDXSCodexis Inc
08/08/202422h05GlobeNewswire Inc.Codexis Reports Second Quarter 2024 Financial ResultsNASDAQ:CDXSCodexis Inc
18/07/202422h05GlobeNewswire Inc.Codexis to Report Second Quarter 2024 Financial Results on August 8NASDAQ:CDXSCodexis Inc
 Showing the most relevant articles for your search:NASDAQ:CDXS

Dernières Valeurs Consultées

EU
SGO
Cie de SaintGobain
NYSE
KO
Coca Cola
COIN
AVAXUSD
Avalanche
EU
HO
Thales
EU
DG
Vinci
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
EU
VK
Vallourec
NASDAQ
NVDA
NVIDIA
EU
RI
Pernod Ricard
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
COIN
ADAUSD
Cardano
NASDAQ
AMZN
Amazon.com
EU
GLE
Societe Generale
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces